Form 4: Phreesia Director Lainie Goldstein Acquires RSUs

Phreesia, Inc. reports that Director Lainie Goldstein acquired 19,290 Restricted Stock Units (RSUs) on June 24, 2026, valued at $9.59 per share.

Summary

• Director Lainie Goldstein acquired 19,290 Restricted Stock Units (RSUs) on June 24, 2026.
• The acquisition was made under the Phreesia, Inc. 2019 Stock Option and Incentive Plan.
• Each RSU represents a contingent right to one share of Phreesia's common stock.
• These RSUs are subject to a deferral election by the director under the Non-Employee Director Deferred Compensation Program.
• Vesting will occur on the earlier of June 24, 2027, or the next annual stockholder meeting.
• The underlying common stock will be delivered 90 days after the director ceases to serve and incurs a 'separation from service'.
• Following this transaction, Lainie Goldstein beneficially owns 70,485 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a standard equity grant to a director rather than a new strategic development or financial performance indicator.

Positives

• Director Lainie Goldstein's acquisition of RSUs indicates continued commitment and alignment with the company's long-term performance.
• The acquisition of 19,290 RSUs demonstrates a significant grant of equity to a key insider.

Risks

• The RSUs are subject to vesting conditions, meaning the director will not immediately receive the underlying common stock.
• Delivery of the common stock is contingent upon the director's continued service and a qualifying separation from service, introducing potential timing uncertainties.
• The value of the RSUs is tied to the future performance of Phreesia's stock price, which is subject to market volatility.

Future Outlook

The RSUs are set to vest on June 24, 2027, or at the next annual stockholder meeting, with the underlying common stock to be delivered 90 days after the director's separation from service.

Industry Context

StockSavvy.ai notes that the issuance of Restricted Stock Units (RSUs) to directors is a common practice in the healthcare technology sector to align executive interests with shareholder value and incentivize long-term performance.

Stakeholder Impact

• Shareholders: The issuance of RSUs is a form of compensation and potential dilution, but also aligns director interests with long-term company performance.
• Employees: This filing is primarily relevant to executive compensation and corporate governance, with indirect impact on employee morale and alignment.
• Management: Lainie Goldstein's compensation package is detailed, reflecting standard executive incentive practices.

Next Steps

• Vesting of RSUs on June 24, 2027, or the next annual stockholder meeting.
• Delivery of common stock 90 days after director's separation from service.

Key Dates

Keywords

Phreesia, PHR, Form 4, Insider Transaction, Restricted Stock Units, RSU, Director Compensation, Equity Award, Securities Exchange Act